Once listed than no more excuses …hey.!, especially with a one year plus of funding.
The assumption that the current valuation is a joke is based on what?, I would think that RIs have valued it based on Company spiel which was/is way ahead of itself; as per the $50 plus internal valuation and ect from two years ago.
There will never be a transparent accounting of what it would cost going forward, the situation would be exactly on par with the WP comment on RIs being ignorant of time frame and costs for the Vaccine.
The “….. so at least we’ll get an opportunity to be fairly valued eventually” comment; will be a litmus test on how long ‘eventually’ IS, with enough funding being available than that should happen pretty quickly, MORE so based on the huge assumption that this stock has been undervalued on the ASX.
Gltah, imo.
Once listed than no more excuses …hey.!, especially with a one...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.90 |
Change
0.200(1.57%) |
Mkt cap ! $272.6M | |||
| Open | High | Low | Value | Volume |
| $12.62 | $12.99 | $12.61 | $210.9K | 16.57K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1099 | $12.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.98 | 246 | 1 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |